Neurology/Psychiatric, BioWorld Asia
RSS

A sleigh full of approvals

FDA brings good tidings, with new drugs for breast cancer, insomnia, schizophrenia and migraine

December 24, 2019

Four new U.S. drug approvals, one accelerated for need, have handed a string of year-end victories to five drugmakers, marking an unusually active start to a week full of global holiday celebrations. Daiichi Sankyo Co. Ltd., Astrazeneca plc, Eisai Inc., Intra-Cellular Therapies Inc. and Allergan plc all secured new approvals from the agency.

China grants conditional approval to Green Valley's GV-971 for Alzheimer's disease

November 6, 2019

By Elise Mak

No Comments

BEIJING – Chinese drug regulators granted conditional approval to Shanghai Green Valley (Group) Co. Ltd.'s marine-derived oligosaccharide, GV-971, to treat Alzheimer's disease (AD), but required further trials to prove the drug's efficacy after marketing.

Sulfide stress as new target?

Schizophrenia biomarker can be detected in human hair

November 6, 2019

By John Fox

No Comments

A subtype of schizophrenia is related to abnormally high brain levels of hydrogen sulfide (H2S), which has important implications for the development of new treatments, according to a study by researchers at the RIKEN Center for Brain Science (CBS) in Japan.

Enabler of inebilizumab: Mitsubishi pact for Viela gets firm $30M up front

October 16, 2019

By Randy Osborne

No Comments

Days after going public, Viela Bio Inc. nailed down a deal with Mitsubishi Tanabe Pharma Corp. to develop and commercialize Viela’s humanized anti-CD19 monoclonal antibody, inebilizumab, in nine Asia regions for the rare disease called neuromyelitis optica spectrum disorder (NMOSD), as well as other potential future indications.

South Korea’s Chong Kun Dang invests in startup Biorchestra targeting AD

October 16, 2019

By Jihyun Kim

No Comments

HONG KONG – South Korean pharmaceutical company Chong Kun Dang Holdings recently invested KRW5 billion (US$4.1 million) in Biorchestra Co. Ltd., a Korean startup based in Daejeon that aims to develop Alzheimer’s dementia treatment based on microRNA.

Thiel calls for improving research grant, regulatory processes to enhance scientific innovation

BioWorld

SANTA CLARA, Calif. – Peter Thiel is not a fan of incremental science. The high-profile venture capital investor, who invests across technology and the life...

Insulet to launch wearable insulin pump this year, works with Dexcom iCGM for closed loop

BioWorld MedTech

SAN FRANCISCO – Insulet Corp. aims to get an FDA approval this year and launch its first interoperable device, the cord-free, wearable insulin device Omnipod...

China launches price war to reshuffle pharma industry; Bayer cuts prices by 90% to secure market

BioWorld

China announced Jan. 17 which further pharmaceutical companies it will buy from under its centralized procurement program that seeks the lowest prices. The price...

Novavax developing nanoparticle vaccine for Wuhan coronavirus

BioWorld

In response to the emergence of a new coronavirus seen recently in China, and now America, Novavax Inc. has initiated development of a vaccine candidate, the...

Lung cancer treatment options much improved, but resistance remains

BioWorld

It is equally fair to say that lung cancer treatment has come a long way, and that it has a long way to go. Speaking at a joint conference by the International...

Neurology/Psychiatric, BioWorld Asia
RSS

FDA brings good tidings, with new drugs for breast cancer, insomnia, schizophrenia and migraine

China grants conditional approval to Green Valley's GV-971 for Alzheimer's disease

Schizophrenia biomarker can be detected in human hair

Enabler of inebilizumab: Mitsubishi pact for Viela gets firm $30M up front

South Korea’s Chong Kun Dang invests in startup Biorchestra targeting AD

Popular Stories

Thiel calls for improving research grant, regulatory processes to enhance scientific innovation

Insulet to launch wearable insulin pump this year, works with Dexcom iCGM for closed loop

China launches price war to reshuffle pharma industry; Bayer cuts prices by 90% to secure market

Novavax developing nanoparticle vaccine for Wuhan coronavirus

Lung cancer treatment options much improved, but resistance remains

BioWorld Premium

Neurology/Psychiatric, BioWorld Asia RSS

Popular Stories

BioWorld Premium

Neurology/Psychiatric, BioWorld Asia
RSS